POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL

• G.M. Chertow,
• P. Vart,
• N. Jongs,
• R.D. Toto,
• J.L. Gorriz,
• F.F. Hou,
• J.J.V. McMurray,
• R. Correa-Rotter,
• P. Rossing,
• C.D. Sjöström,
• B.V. Stefánsson,
• A.M. Langkilde,
• D.C. Wheeler,
• H. Lambers Heerspink

Affiliations

G.M. Chertow

Stanford University School of Medicine, Departments of Medicine and Epidemiology and Population Health, Stanford, United States

P. Vart

University of Groningen University Medical Center Groningen, Department Clinical Pharmacy and Pharmacology, Groningen, Netherlands

N. Jongs

University of Groningen University Medical Center Groningen, Department Clinical Pharmacy and Pharmacology, Groningen, Netherlands

R.D. Toto

UT Southwestern Medical Center, Department of Internal Medicine, Dallas, United States

J.L. Gorriz

University Clinic Hospital- INCLIVA- University of Valencia, Department of Nephrology, Valencia, Spain

F.F. Hou

Nanfang Hospital- Southern Medical University- National Clinical Research Center for Kidney Disease, Division of Nephrology, Guangzhou, China

J.J.V. McMurray

University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, United Kingdom

R. Correa-Rotter

National Medical Science and Nutrition Institute Salvador Zubirán, Department of Nephrology and Mineral Metabolism, Mexico City, Mexico

P. Rossing

University of Copenhagen, Department of Clinical Medicine, Copenhagen, Denmark

C.D. Sjöström

AstraZeneca, Late-stage Development Cardiovascular Renal and Metabolism Biopharmaceuticals R&D, Gothenburg, Sweden

B.V. Stefánsson

AstraZeneca, Late-stage Development Cardiovascular Renal and Metabolism Biopharmaceuticals R&D, Gothenburg, Sweden

A.M. Langkilde

AstraZeneca, Late-stage Development Cardiovascular Renal and Metabolism Biopharmaceuticals R&D, Gothenburg, Sweden

D.C. Wheeler

University College London, Department of Renal Medicine, London, United Kingdom

H. Lambers Heerspink

University of Groningen University Medical Center Groningen, Department Clinical Pharmacy and Pharmacology, Groningen, Netherlands